nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—atherosclerosis	0.561	1	CbGaD
Octreotide—MPO—superior mesenteric artery—atherosclerosis	0.0344	0.687	CbGeAlD
Octreotide—MPO—artery—atherosclerosis	0.00368	0.0735	CbGeAlD
Octreotide—MPO—endothelium—atherosclerosis	0.00311	0.0621	CbGeAlD
Octreotide—MPO—blood vessel—atherosclerosis	0.00287	0.0573	CbGeAlD
Octreotide—SSTR1—liver—atherosclerosis	0.00246	0.0491	CbGeAlD
Octreotide—MPO—connective tissue—atherosclerosis	0.00147	0.0294	CbGeAlD
Octreotide—MPO—cardiovascular system—atherosclerosis	0.00128	0.0255	CbGeAlD
Octreotide—MPO—liver—atherosclerosis	0.000791	0.0158	CbGeAlD
Octreotide—Muscle spasms—Ezetimibe—atherosclerosis	0.000316	0.0015	CcSEcCtD
Octreotide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000316	0.0015	CcSEcCtD
Octreotide—Vision blurred—Lovastatin—atherosclerosis	0.000316	0.0015	CcSEcCtD
Octreotide—Mental disorder—Simvastatin—atherosclerosis	0.000315	0.0015	CcSEcCtD
Octreotide—Tremor—Lovastatin—atherosclerosis	0.000314	0.00149	CcSEcCtD
Octreotide—Visual impairment—Pravastatin—atherosclerosis	0.000314	0.00149	CcSEcCtD
Octreotide—Erythema—Simvastatin—atherosclerosis	0.000313	0.00149	CcSEcCtD
Octreotide—Ill-defined disorder—Lovastatin—atherosclerosis	0.000311	0.00148	CcSEcCtD
Octreotide—Flatulence—Simvastatin—atherosclerosis	0.000309	0.00147	CcSEcCtD
Octreotide—Tinnitus—Niacin—atherosclerosis	0.000308	0.00147	CcSEcCtD
Octreotide—Flushing—Niacin—atherosclerosis	0.000307	0.00146	CcSEcCtD
Octreotide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000305	0.00145	CcSEcCtD
Octreotide—Anaemia—Ezetimibe—atherosclerosis	0.000304	0.00145	CcSEcCtD
Octreotide—Tinnitus—Pravastatin—atherosclerosis	0.000303	0.00144	CcSEcCtD
Octreotide—Malaise—Lovastatin—atherosclerosis	0.000302	0.00144	CcSEcCtD
Octreotide—Flushing—Pravastatin—atherosclerosis	0.000302	0.00144	CcSEcCtD
Octreotide—Cardiac disorder—Pravastatin—atherosclerosis	0.000302	0.00144	CcSEcCtD
Octreotide—Muscle spasms—Simvastatin—atherosclerosis	0.000301	0.00143	CcSEcCtD
Octreotide—Vertigo—Lovastatin—atherosclerosis	0.000301	0.00143	CcSEcCtD
Octreotide—Malaise—Ezetimibe—atherosclerosis	0.000296	0.00141	CcSEcCtD
Octreotide—Vision blurred—Simvastatin—atherosclerosis	0.000295	0.00141	CcSEcCtD
Octreotide—Arrhythmia—Niacin—atherosclerosis	0.000295	0.00141	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000294	0.0014	CcSEcCtD
Octreotide—Tremor—Simvastatin—atherosclerosis	0.000293	0.0014	CcSEcCtD
Octreotide—Alopecia—Niacin—atherosclerosis	0.000292	0.00139	CcSEcCtD
Octreotide—Insomnia—Rosuvastatin—atherosclerosis	0.000292	0.00139	CcSEcCtD
Octreotide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000291	0.00138	CcSEcCtD
Octreotide—Arrhythmia—Pravastatin—atherosclerosis	0.000291	0.00138	CcSEcCtD
Octreotide—Palpitations—Ezetimibe—atherosclerosis	0.00029	0.00138	CcSEcCtD
Octreotide—Paraesthesia—Rosuvastatin—atherosclerosis	0.00029	0.00138	CcSEcCtD
Octreotide—Anaemia—Simvastatin—atherosclerosis	0.00029	0.00138	CcSEcCtD
Octreotide—Erythema—Niacin—atherosclerosis	0.000288	0.00137	CcSEcCtD
Octreotide—Malnutrition—Niacin—atherosclerosis	0.000288	0.00137	CcSEcCtD
Octreotide—Alopecia—Pravastatin—atherosclerosis	0.000287	0.00137	CcSEcCtD
Octreotide—Cough—Ezetimibe—atherosclerosis	0.000287	0.00137	CcSEcCtD
Octreotide—Arthralgia—Lovastatin—atherosclerosis	0.000285	0.00136	CcSEcCtD
Octreotide—Chest pain—Lovastatin—atherosclerosis	0.000285	0.00136	CcSEcCtD
Octreotide—Myalgia—Lovastatin—atherosclerosis	0.000285	0.00136	CcSEcCtD
Octreotide—Anxiety—Lovastatin—atherosclerosis	0.000284	0.00135	CcSEcCtD
Octreotide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000284	0.00135	CcSEcCtD
Octreotide—Hypertension—Ezetimibe—atherosclerosis	0.000284	0.00135	CcSEcCtD
Octreotide—Flatulence—Niacin—atherosclerosis	0.000283	0.00135	CcSEcCtD
Octreotide—Malaise—Simvastatin—atherosclerosis	0.000282	0.00135	CcSEcCtD
Octreotide—Tension—Niacin—atherosclerosis	0.000282	0.00134	CcSEcCtD
Octreotide—Discomfort—Lovastatin—atherosclerosis	0.000282	0.00134	CcSEcCtD
Octreotide—Vertigo—Simvastatin—atherosclerosis	0.000281	0.00134	CcSEcCtD
Octreotide—Chest pain—Ezetimibe—atherosclerosis	0.00028	0.00133	CcSEcCtD
Octreotide—Arthralgia—Ezetimibe—atherosclerosis	0.00028	0.00133	CcSEcCtD
Octreotide—Myalgia—Ezetimibe—atherosclerosis	0.00028	0.00133	CcSEcCtD
Octreotide—Nervousness—Niacin—atherosclerosis	0.000279	0.00133	CcSEcCtD
Octreotide—Flatulence—Pravastatin—atherosclerosis	0.000279	0.00133	CcSEcCtD
Octreotide—Dry mouth—Lovastatin—atherosclerosis	0.000279	0.00133	CcSEcCtD
Octreotide—Tension—Pravastatin—atherosclerosis	0.000278	0.00132	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000278	0.00132	CcSEcCtD
Octreotide—Muscle spasms—Niacin—atherosclerosis	0.000277	0.00132	CcSEcCtD
Octreotide—Discomfort—Ezetimibe—atherosclerosis	0.000276	0.00132	CcSEcCtD
Octreotide—Constipation—Rosuvastatin—atherosclerosis	0.000276	0.00131	CcSEcCtD
Octreotide—Pain—Rosuvastatin—atherosclerosis	0.000276	0.00131	CcSEcCtD
Octreotide—Nervousness—Pravastatin—atherosclerosis	0.000275	0.00131	CcSEcCtD
Octreotide—Dry mouth—Ezetimibe—atherosclerosis	0.000273	0.0013	CcSEcCtD
Octreotide—Anaphylactic shock—Lovastatin—atherosclerosis	0.000273	0.0013	CcSEcCtD
Octreotide—Muscle spasms—Pravastatin—atherosclerosis	0.000272	0.0013	CcSEcCtD
Octreotide—Infection—Lovastatin—atherosclerosis	0.000272	0.00129	CcSEcCtD
Octreotide—Vision blurred—Niacin—atherosclerosis	0.000271	0.00129	CcSEcCtD
Octreotide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000268	0.00128	CcSEcCtD
Octreotide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000268	0.00127	CcSEcCtD
Octreotide—Vision blurred—Pravastatin—atherosclerosis	0.000267	0.00127	CcSEcCtD
Octreotide—Myalgia—Simvastatin—atherosclerosis	0.000267	0.00127	CcSEcCtD
Octreotide—Chest pain—Simvastatin—atherosclerosis	0.000267	0.00127	CcSEcCtD
Octreotide—Arthralgia—Simvastatin—atherosclerosis	0.000267	0.00127	CcSEcCtD
Octreotide—Infection—Ezetimibe—atherosclerosis	0.000266	0.00127	CcSEcCtD
Octreotide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000266	0.00127	CcSEcCtD
Octreotide—Anxiety—Simvastatin—atherosclerosis	0.000266	0.00127	CcSEcCtD
Octreotide—Tremor—Pravastatin—atherosclerosis	0.000265	0.00126	CcSEcCtD
Octreotide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000264	0.00126	CcSEcCtD
Octreotide—Discomfort—Simvastatin—atherosclerosis	0.000263	0.00125	CcSEcCtD
Octreotide—Nervous system disorder—Ezetimibe—atherosclerosis	0.000263	0.00125	CcSEcCtD
Octreotide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000263	0.00125	CcSEcCtD
Octreotide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000262	0.00125	CcSEcCtD
Octreotide—Anaemia—Pravastatin—atherosclerosis	0.000262	0.00125	CcSEcCtD
Octreotide—Anorexia—Lovastatin—atherosclerosis	0.000261	0.00124	CcSEcCtD
Octreotide—Skin disorder—Ezetimibe—atherosclerosis	0.00026	0.00124	CcSEcCtD
Octreotide—Vertigo—Niacin—atherosclerosis	0.000258	0.00123	CcSEcCtD
Octreotide—Syncope—Niacin—atherosclerosis	0.000258	0.00123	CcSEcCtD
Octreotide—Urticaria—Rosuvastatin—atherosclerosis	0.000256	0.00122	CcSEcCtD
Octreotide—Oedema—Simvastatin—atherosclerosis	0.000256	0.00122	CcSEcCtD
Octreotide—Anaphylactic shock—Simvastatin—atherosclerosis	0.000256	0.00122	CcSEcCtD
Octreotide—Malaise—Pravastatin—atherosclerosis	0.000255	0.00122	CcSEcCtD
Octreotide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000255	0.00121	CcSEcCtD
Octreotide—Vertigo—Pravastatin—atherosclerosis	0.000254	0.00121	CcSEcCtD
Octreotide—Palpitations—Niacin—atherosclerosis	0.000254	0.00121	CcSEcCtD
Octreotide—Infection—Simvastatin—atherosclerosis	0.000254	0.00121	CcSEcCtD
Octreotide—Loss of consciousness—Niacin—atherosclerosis	0.000253	0.0012	CcSEcCtD
Octreotide—Cough—Niacin—atherosclerosis	0.000251	0.0012	CcSEcCtD
Octreotide—Thrombocytopenia—Simvastatin—atherosclerosis	0.00025	0.00119	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000249	0.00119	CcSEcCtD
Octreotide—Insomnia—Lovastatin—atherosclerosis	0.000247	0.00118	CcSEcCtD
Octreotide—Cough—Pravastatin—atherosclerosis	0.000247	0.00118	CcSEcCtD
Octreotide—Paraesthesia—Lovastatin—atherosclerosis	0.000245	0.00117	CcSEcCtD
Octreotide—Myalgia—Niacin—atherosclerosis	0.000245	0.00117	CcSEcCtD
Octreotide—Arthralgia—Niacin—atherosclerosis	0.000245	0.00117	CcSEcCtD
Octreotide—Hypertension—Pravastatin—atherosclerosis	0.000244	0.00116	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000244	0.00116	CcSEcCtD
Octreotide—Anorexia—Simvastatin—atherosclerosis	0.000244	0.00116	CcSEcCtD
Octreotide—Dyspnoea—Lovastatin—atherosclerosis	0.000244	0.00116	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000243	0.00116	CcSEcCtD
Octreotide—Insomnia—Ezetimibe—atherosclerosis	0.000242	0.00115	CcSEcCtD
Octreotide—Chest pain—Pravastatin—atherosclerosis	0.000241	0.00115	CcSEcCtD
Octreotide—Arthralgia—Pravastatin—atherosclerosis	0.000241	0.00115	CcSEcCtD
Octreotide—Myalgia—Pravastatin—atherosclerosis	0.000241	0.00115	CcSEcCtD
Octreotide—Paraesthesia—Ezetimibe—atherosclerosis	0.000241	0.00115	CcSEcCtD
Octreotide—Dyspepsia—Lovastatin—atherosclerosis	0.000241	0.00115	CcSEcCtD
Octreotide—Anxiety—Pravastatin—atherosclerosis	0.00024	0.00114	CcSEcCtD
Octreotide—Dry mouth—Niacin—atherosclerosis	0.000239	0.00114	CcSEcCtD
Octreotide—Dyspnoea—Ezetimibe—atherosclerosis	0.000239	0.00114	CcSEcCtD
Octreotide—Discomfort—Pravastatin—atherosclerosis	0.000238	0.00113	CcSEcCtD
Octreotide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000238	0.00113	CcSEcCtD
Octreotide—Decreased appetite—Lovastatin—atherosclerosis	0.000238	0.00113	CcSEcCtD
Octreotide—Dyspepsia—Ezetimibe—atherosclerosis	0.000236	0.00112	CcSEcCtD
Octreotide—Fatigue—Lovastatin—atherosclerosis	0.000236	0.00112	CcSEcCtD
Octreotide—Oedema—Niacin—atherosclerosis	0.000235	0.00112	CcSEcCtD
Octreotide—Anaphylactic shock—Niacin—atherosclerosis	0.000235	0.00112	CcSEcCtD
Octreotide—Pain—Lovastatin—atherosclerosis	0.000234	0.00111	CcSEcCtD
Octreotide—Constipation—Lovastatin—atherosclerosis	0.000234	0.00111	CcSEcCtD
Octreotide—Decreased appetite—Ezetimibe—atherosclerosis	0.000233	0.00111	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000233	0.00111	CcSEcCtD
Octreotide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000231	0.0011	CcSEcCtD
Octreotide—Asthenia—Rosuvastatin—atherosclerosis	0.000231	0.0011	CcSEcCtD
Octreotide—Insomnia—Simvastatin—atherosclerosis	0.000231	0.0011	CcSEcCtD
Octreotide—Oedema—Pravastatin—atherosclerosis	0.000231	0.0011	CcSEcCtD
Octreotide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000231	0.0011	CcSEcCtD
Octreotide—Fatigue—Ezetimibe—atherosclerosis	0.000231	0.0011	CcSEcCtD
Octreotide—Shock—Niacin—atherosclerosis	0.000231	0.0011	CcSEcCtD
Octreotide—Infection—Pravastatin—atherosclerosis	0.00023	0.00109	CcSEcCtD
Octreotide—Paraesthesia—Simvastatin—atherosclerosis	0.00023	0.00109	CcSEcCtD
Octreotide—Constipation—Ezetimibe—atherosclerosis	0.000229	0.00109	CcSEcCtD
Octreotide—Pain—Ezetimibe—atherosclerosis	0.000229	0.00109	CcSEcCtD
Octreotide—Tachycardia—Niacin—atherosclerosis	0.000229	0.00109	CcSEcCtD
Octreotide—Pruritus—Rosuvastatin—atherosclerosis	0.000228	0.00109	CcSEcCtD
Octreotide—Skin disorder—Niacin—atherosclerosis	0.000228	0.00109	CcSEcCtD
Octreotide—Dyspnoea—Simvastatin—atherosclerosis	0.000228	0.00109	CcSEcCtD
Octreotide—Hyperhidrosis—Niacin—atherosclerosis	0.000227	0.00108	CcSEcCtD
Octreotide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000226	0.00108	CcSEcCtD
Octreotide—Feeling abnormal—Lovastatin—atherosclerosis	0.000225	0.00107	CcSEcCtD
Octreotide—Dyspepsia—Simvastatin—atherosclerosis	0.000225	0.00107	CcSEcCtD
Octreotide—Anorexia—Niacin—atherosclerosis	0.000224	0.00107	CcSEcCtD
Octreotide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000223	0.00106	CcSEcCtD
Octreotide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000223	0.00106	CcSEcCtD
Octreotide—Decreased appetite—Simvastatin—atherosclerosis	0.000222	0.00106	CcSEcCtD
Octreotide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000221	0.00105	CcSEcCtD
Octreotide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000221	0.00105	CcSEcCtD
Octreotide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000221	0.00105	CcSEcCtD
Octreotide—Fatigue—Simvastatin—atherosclerosis	0.00022	0.00105	CcSEcCtD
Octreotide—Anorexia—Pravastatin—atherosclerosis	0.00022	0.00105	CcSEcCtD
Octreotide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000219	0.00104	CcSEcCtD
Octreotide—Constipation—Simvastatin—atherosclerosis	0.000219	0.00104	CcSEcCtD
Octreotide—Pain—Simvastatin—atherosclerosis	0.000219	0.00104	CcSEcCtD
Octreotide—Urticaria—Lovastatin—atherosclerosis	0.000217	0.00103	CcSEcCtD
Octreotide—Body temperature increased—Lovastatin—atherosclerosis	0.000216	0.00103	CcSEcCtD
Octreotide—Abdominal pain—Lovastatin—atherosclerosis	0.000216	0.00103	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000214	0.00102	CcSEcCtD
Octreotide—Dizziness—Rosuvastatin—atherosclerosis	0.000213	0.00102	CcSEcCtD
Octreotide—Urticaria—Ezetimibe—atherosclerosis	0.000213	0.00101	CcSEcCtD
Octreotide—Insomnia—Niacin—atherosclerosis	0.000212	0.00101	CcSEcCtD
Octreotide—Body temperature increased—Ezetimibe—atherosclerosis	0.000212	0.00101	CcSEcCtD
Octreotide—Abdominal pain—Ezetimibe—atherosclerosis	0.000212	0.00101	CcSEcCtD
Octreotide—Paraesthesia—Niacin—atherosclerosis	0.000211	0.001	CcSEcCtD
Octreotide—Feeling abnormal—Simvastatin—atherosclerosis	0.000211	0.001	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000211	0.001	CcSEcCtD
Octreotide—Dyspnoea—Niacin—atherosclerosis	0.000209	0.000997	CcSEcCtD
Octreotide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000209	0.000996	CcSEcCtD
Octreotide—Insomnia—Pravastatin—atherosclerosis	0.000209	0.000996	CcSEcCtD
Octreotide—Somnolence—Niacin—atherosclerosis	0.000209	0.000994	CcSEcCtD
Octreotide—Paraesthesia—Pravastatin—atherosclerosis	0.000208	0.000988	CcSEcCtD
Octreotide—Dyspepsia—Niacin—atherosclerosis	0.000207	0.000984	CcSEcCtD
Octreotide—Dyspnoea—Pravastatin—atherosclerosis	0.000206	0.000981	CcSEcCtD
Octreotide—Decreased appetite—Niacin—atherosclerosis	0.000204	0.000972	CcSEcCtD
Octreotide—Dyspepsia—Pravastatin—atherosclerosis	0.000203	0.000969	CcSEcCtD
Octreotide—Rash—Rosuvastatin—atherosclerosis	0.000203	0.000969	CcSEcCtD
Octreotide—Dermatitis—Rosuvastatin—atherosclerosis	0.000203	0.000968	CcSEcCtD
Octreotide—Urticaria—Simvastatin—atherosclerosis	0.000203	0.000967	CcSEcCtD
Octreotide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000203	0.000965	CcSEcCtD
Octreotide—Body temperature increased—Simvastatin—atherosclerosis	0.000202	0.000963	CcSEcCtD
Octreotide—Abdominal pain—Simvastatin—atherosclerosis	0.000202	0.000963	CcSEcCtD
Octreotide—Headache—Rosuvastatin—atherosclerosis	0.000202	0.000962	CcSEcCtD
Octreotide—Hypersensitivity—Lovastatin—atherosclerosis	0.000201	0.000959	CcSEcCtD
Octreotide—Decreased appetite—Pravastatin—atherosclerosis	0.000201	0.000957	CcSEcCtD
Octreotide—Pain—Niacin—atherosclerosis	0.000201	0.000956	CcSEcCtD
Octreotide—Fatigue—Pravastatin—atherosclerosis	0.000199	0.000949	CcSEcCtD
Octreotide—Pain—Pravastatin—atherosclerosis	0.000198	0.000941	CcSEcCtD
Octreotide—Constipation—Pravastatin—atherosclerosis	0.000198	0.000941	CcSEcCtD
Octreotide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000198	0.000941	CcSEcCtD
Octreotide—Asthenia—Lovastatin—atherosclerosis	0.000196	0.000934	CcSEcCtD
Octreotide—Pruritus—Lovastatin—atherosclerosis	0.000193	0.000921	CcSEcCtD
Octreotide—Asthenia—Ezetimibe—atherosclerosis	0.000192	0.000916	CcSEcCtD
Octreotide—Gastrointestinal pain—Niacin—atherosclerosis	0.000192	0.000914	CcSEcCtD
Octreotide—Nausea—Rosuvastatin—atherosclerosis	0.000192	0.000912	CcSEcCtD
Octreotide—Feeling abnormal—Pravastatin—atherosclerosis	0.00019	0.000907	CcSEcCtD
Octreotide—Pruritus—Ezetimibe—atherosclerosis	0.00019	0.000903	CcSEcCtD
Octreotide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000189	0.0009	CcSEcCtD
Octreotide—Hypersensitivity—Simvastatin—atherosclerosis	0.000188	0.000897	CcSEcCtD
Octreotide—Diarrhoea—Lovastatin—atherosclerosis	0.000187	0.000891	CcSEcCtD
Octreotide—Urticaria—Niacin—atherosclerosis	0.000186	0.000888	CcSEcCtD
Octreotide—Abdominal pain—Niacin—atherosclerosis	0.000186	0.000884	CcSEcCtD
Octreotide—Body temperature increased—Niacin—atherosclerosis	0.000186	0.000884	CcSEcCtD
Octreotide—Urticaria—Pravastatin—atherosclerosis	0.000184	0.000875	CcSEcCtD
Octreotide—Asthenia—Simvastatin—atherosclerosis	0.000183	0.000874	CcSEcCtD
Octreotide—Diarrhoea—Ezetimibe—atherosclerosis	0.000183	0.000874	CcSEcCtD
Octreotide—Abdominal pain—Pravastatin—atherosclerosis	0.000183	0.00087	CcSEcCtD
Octreotide—Body temperature increased—Pravastatin—atherosclerosis	0.000183	0.00087	CcSEcCtD
Octreotide—Pruritus—Simvastatin—atherosclerosis	0.000181	0.000861	CcSEcCtD
Octreotide—Dizziness—Lovastatin—atherosclerosis	0.000181	0.000861	CcSEcCtD
Octreotide—Dizziness—Ezetimibe—atherosclerosis	0.000177	0.000844	CcSEcCtD
Octreotide—Diarrhoea—Simvastatin—atherosclerosis	0.000175	0.000833	CcSEcCtD
Octreotide—Vomiting—Lovastatin—atherosclerosis	0.000174	0.000828	CcSEcCtD
Octreotide—Hypersensitivity—Niacin—atherosclerosis	0.000173	0.000824	CcSEcCtD
Octreotide—Rash—Lovastatin—atherosclerosis	0.000172	0.000821	CcSEcCtD
Octreotide—Dermatitis—Lovastatin—atherosclerosis	0.000172	0.00082	CcSEcCtD
Octreotide—Headache—Lovastatin—atherosclerosis	0.000171	0.000816	CcSEcCtD
Octreotide—Vomiting—Ezetimibe—atherosclerosis	0.00017	0.000812	CcSEcCtD
Octreotide—Hypersensitivity—Pravastatin—atherosclerosis	0.00017	0.000811	CcSEcCtD
Octreotide—Dizziness—Simvastatin—atherosclerosis	0.000169	0.000805	CcSEcCtD
Octreotide—Rash—Ezetimibe—atherosclerosis	0.000169	0.000805	CcSEcCtD
Octreotide—Dermatitis—Ezetimibe—atherosclerosis	0.000169	0.000804	CcSEcCtD
Octreotide—Asthenia—Niacin—atherosclerosis	0.000168	0.000802	CcSEcCtD
Octreotide—Headache—Ezetimibe—atherosclerosis	0.000168	0.0008	CcSEcCtD
Octreotide—Pruritus—Niacin—atherosclerosis	0.000166	0.000791	CcSEcCtD
Octreotide—Asthenia—Pravastatin—atherosclerosis	0.000166	0.00079	CcSEcCtD
Octreotide—Pruritus—Pravastatin—atherosclerosis	0.000164	0.000779	CcSEcCtD
Octreotide—Vomiting—Simvastatin—atherosclerosis	0.000163	0.000774	CcSEcCtD
Octreotide—Nausea—Lovastatin—atherosclerosis	0.000162	0.000773	CcSEcCtD
Octreotide—Rash—Simvastatin—atherosclerosis	0.000161	0.000768	CcSEcCtD
Octreotide—Dermatitis—Simvastatin—atherosclerosis	0.000161	0.000767	CcSEcCtD
Octreotide—Diarrhoea—Niacin—atherosclerosis	0.000161	0.000765	CcSEcCtD
Octreotide—Headache—Simvastatin—atherosclerosis	0.00016	0.000763	CcSEcCtD
Octreotide—Nausea—Ezetimibe—atherosclerosis	0.000159	0.000758	CcSEcCtD
Octreotide—Diarrhoea—Pravastatin—atherosclerosis	0.000158	0.000753	CcSEcCtD
Octreotide—Dizziness—Niacin—atherosclerosis	0.000155	0.000739	CcSEcCtD
Octreotide—Dizziness—Pravastatin—atherosclerosis	0.000153	0.000728	CcSEcCtD
Octreotide—Nausea—Simvastatin—atherosclerosis	0.000152	0.000723	CcSEcCtD
Octreotide—Vomiting—Niacin—atherosclerosis	0.000149	0.000711	CcSEcCtD
Octreotide—Rash—Niacin—atherosclerosis	0.000148	0.000705	CcSEcCtD
Octreotide—Dermatitis—Niacin—atherosclerosis	0.000148	0.000704	CcSEcCtD
Octreotide—Headache—Niacin—atherosclerosis	0.000147	0.0007	CcSEcCtD
Octreotide—Vomiting—Pravastatin—atherosclerosis	0.000147	0.0007	CcSEcCtD
Octreotide—Rash—Pravastatin—atherosclerosis	0.000146	0.000694	CcSEcCtD
Octreotide—Dermatitis—Pravastatin—atherosclerosis	0.000146	0.000693	CcSEcCtD
Octreotide—Headache—Pravastatin—atherosclerosis	0.000145	0.00069	CcSEcCtD
Octreotide—Nausea—Niacin—atherosclerosis	0.000139	0.000664	CcSEcCtD
Octreotide—Nausea—Pravastatin—atherosclerosis	0.000137	0.000654	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—CXCL8—atherosclerosis	5.82e-05	0.000325	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EDN1—atherosclerosis	5.81e-05	0.000325	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CYBA—atherosclerosis	5.79e-05	0.000324	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EDN1—atherosclerosis	5.77e-05	0.000323	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL5—atherosclerosis	5.77e-05	0.000322	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AGT—atherosclerosis	5.76e-05	0.000322	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CG—atherosclerosis	5.74e-05	0.000321	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL5—atherosclerosis	5.73e-05	0.00032	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL3—atherosclerosis	5.71e-05	0.000319	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—F2—atherosclerosis	5.68e-05	0.000318	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GHRL—atherosclerosis	5.67e-05	0.000317	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PARP1—atherosclerosis	5.67e-05	0.000317	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PLAT—atherosclerosis	5.67e-05	0.000317	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—LPL—atherosclerosis	5.6e-05	0.000313	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PRKCG—atherosclerosis	5.48e-05	0.000306	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NCF1—atherosclerosis	5.47e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VWF—atherosclerosis	5.46e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PRKCG—atherosclerosis	5.45e-05	0.000304	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—F2—atherosclerosis	5.45e-05	0.000304	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CG—atherosclerosis	5.44e-05	0.000304	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOC3—atherosclerosis	5.43e-05	0.000303	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LDLR—atherosclerosis	5.39e-05	0.000301	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—F2—atherosclerosis	5.32e-05	0.000297	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AGT—atherosclerosis	5.31e-05	0.000297	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SPP1—atherosclerosis	5.31e-05	0.000297	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CXCL8—atherosclerosis	5.28e-05	0.000295	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL3—atherosclerosis	5.27e-05	0.000294	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AGT—atherosclerosis	5.23e-05	0.000292	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CG—atherosclerosis	5.21e-05	0.000291	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KNG1—atherosclerosis	5.19e-05	0.00029	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EDNRA—atherosclerosis	5.16e-05	0.000288	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR2—atherosclerosis	5.16e-05	0.000288	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGTR1—atherosclerosis	5.16e-05	0.000288	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CYBA—atherosclerosis	5.14e-05	0.000287	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CG—atherosclerosis	5.09e-05	0.000285	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCL2—atherosclerosis	5.06e-05	0.000283	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NCF1—atherosclerosis	5.04e-05	0.000282	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GHRL—atherosclerosis	5.03e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PARP1—atherosclerosis	5.03e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PLAT—atherosclerosis	5.03e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PLG—atherosclerosis	5.03e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KNG1—atherosclerosis	4.98e-05	0.000278	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGTR1—atherosclerosis	4.95e-05	0.000277	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PDGFB—atherosclerosis	4.91e-05	0.000274	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—F2—atherosclerosis	4.91e-05	0.000274	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCL2—atherosclerosis	4.85e-05	0.000271	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—F2—atherosclerosis	4.83e-05	0.00027	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGT—atherosclerosis	4.82e-05	0.00027	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PLG—atherosclerosis	4.82e-05	0.00027	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGT—atherosclerosis	4.79e-05	0.000268	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EDNRA—atherosclerosis	4.76e-05	0.000266	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR2—atherosclerosis	4.76e-05	0.000266	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SOCS3—atherosclerosis	4.76e-05	0.000266	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CYBA—atherosclerosis	4.74e-05	0.000265	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CG—atherosclerosis	4.7e-05	0.000263	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—LEP—atherosclerosis	4.7e-05	0.000262	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APOE—atherosclerosis	4.7e-05	0.000262	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CAV1—atherosclerosis	4.65e-05	0.00026	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLAT—atherosclerosis	4.64e-05	0.000259	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PARP1—atherosclerosis	4.64e-05	0.000259	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GHRL—atherosclerosis	4.64e-05	0.000259	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APOA1—atherosclerosis	4.64e-05	0.000259	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CG—atherosclerosis	4.62e-05	0.000258	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP3—atherosclerosis	4.6e-05	0.000257	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF2—atherosclerosis	4.58e-05	0.000256	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SOCS3—atherosclerosis	4.57e-05	0.000255	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ESR1—atherosclerosis	4.48e-05	0.000251	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—F2—atherosclerosis	4.46e-05	0.000249	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOB—atherosclerosis	4.45e-05	0.000249	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—F2—atherosclerosis	4.43e-05	0.000247	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KNG1—atherosclerosis	4.41e-05	0.000247	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP3—atherosclerosis	4.41e-05	0.000247	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCL8—atherosclerosis	4.41e-05	0.000246	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF2—atherosclerosis	4.39e-05	0.000245	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGTR1—atherosclerosis	4.39e-05	0.000245	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EDN1—atherosclerosis	4.38e-05	0.000245	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL5—atherosclerosis	4.34e-05	0.000243	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCL2—atherosclerosis	4.31e-05	0.000241	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PLG—atherosclerosis	4.28e-05	0.000239	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CG—atherosclerosis	4.27e-05	0.000238	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOB—atherosclerosis	4.26e-05	0.000238	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LPL—atherosclerosis	4.25e-05	0.000237	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CG—atherosclerosis	4.24e-05	0.000237	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL8—atherosclerosis	4.23e-05	0.000236	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EDN1—atherosclerosis	4.2e-05	0.000234	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL5—atherosclerosis	4.16e-05	0.000233	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PRKCG—atherosclerosis	4.13e-05	0.000231	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KNG1—atherosclerosis	4.07e-05	0.000228	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LPL—atherosclerosis	4.07e-05	0.000227	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—MAPK3—atherosclerosis	4.06e-05	0.000227	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGTR1—atherosclerosis	4.05e-05	0.000226	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SOCS3—atherosclerosis	4.05e-05	0.000226	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SPP1—atherosclerosis	4.02e-05	0.000225	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—INS—atherosclerosis	4.01e-05	0.000224	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL8—atherosclerosis	4e-05	0.000224	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL2—atherosclerosis	3.97e-05	0.000222	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PRKCG—atherosclerosis	3.96e-05	0.000221	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL2—atherosclerosis	3.95e-05	0.000221	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLG—atherosclerosis	3.95e-05	0.000221	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP3—atherosclerosis	3.91e-05	0.000219	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF2—atherosclerosis	3.89e-05	0.000218	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IGF1—atherosclerosis	3.88e-05	0.000217	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SPP1—atherosclerosis	3.86e-05	0.000215	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL8—atherosclerosis	3.84e-05	0.000215	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOB—atherosclerosis	3.78e-05	0.000211	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL8—atherosclerosis	3.75e-05	0.00021	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SOCS3—atherosclerosis	3.74e-05	0.000209	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PDGFB—atherosclerosis	3.72e-05	0.000208	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EDN1—atherosclerosis	3.72e-05	0.000208	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL5—atherosclerosis	3.69e-05	0.000206	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SERPINE1—atherosclerosis	3.68e-05	0.000206	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGT—atherosclerosis	3.63e-05	0.000203	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP3—atherosclerosis	3.61e-05	0.000202	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LPL—atherosclerosis	3.61e-05	0.000202	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF2—atherosclerosis	3.59e-05	0.000201	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PDGFB—atherosclerosis	3.57e-05	0.000199	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LEP—atherosclerosis	3.56e-05	0.000199	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—atherosclerosis	3.56e-05	0.000199	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CAV1—atherosclerosis	3.53e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOS3—atherosclerosis	3.52e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOA1—atherosclerosis	3.52e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PRKCG—atherosclerosis	3.51e-05	0.000196	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOB—atherosclerosis	3.49e-05	0.000195	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGT—atherosclerosis	3.48e-05	0.000195	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—atherosclerosis	3.46e-05	0.000193	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EDN1—atherosclerosis	3.43e-05	0.000192	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SPP1—atherosclerosis	3.42e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LEP—atherosclerosis	3.41e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—atherosclerosis	3.41e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL5—atherosclerosis	3.41e-05	0.00019	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—atherosclerosis	3.4e-05	0.00019	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ESR1—atherosclerosis	3.4e-05	0.00019	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CAV1—atherosclerosis	3.38e-05	0.000189	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOA1—atherosclerosis	3.37e-05	0.000189	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—F2—atherosclerosis	3.36e-05	0.000188	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LPL—atherosclerosis	3.33e-05	0.000186	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ESR1—atherosclerosis	3.26e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCG—atherosclerosis	3.24e-05	0.000181	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—F2—atherosclerosis	3.22e-05	0.00018	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—atherosclerosis	3.21e-05	0.00018	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PDGFB—atherosclerosis	3.16e-05	0.000177	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SPP1—atherosclerosis	3.16e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—atherosclerosis	3.14e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—atherosclerosis	3.12e-05	0.000174	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGT—atherosclerosis	3.09e-05	0.000173	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—atherosclerosis	3.08e-05	0.000172	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK3—atherosclerosis	3.08e-05	0.000172	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—INS—atherosclerosis	3.04e-05	0.00017	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEP—atherosclerosis	3.03e-05	0.000169	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—atherosclerosis	3.03e-05	0.000169	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—atherosclerosis	3.01e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CAV1—atherosclerosis	3e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOA1—atherosclerosis	2.99e-05	0.000167	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL2—atherosclerosis	2.99e-05	0.000167	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—atherosclerosis	2.97e-05	0.000166	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK3—atherosclerosis	2.95e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1—atherosclerosis	2.94e-05	0.000164	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PDGFB—atherosclerosis	2.92e-05	0.000163	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—INS—atherosclerosis	2.91e-05	0.000163	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ESR1—atherosclerosis	2.89e-05	0.000161	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL2—atherosclerosis	2.87e-05	0.00016	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—F2—atherosclerosis	2.85e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGT—atherosclerosis	2.85e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—atherosclerosis	2.82e-05	0.000158	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1—atherosclerosis	2.82e-05	0.000158	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SERPINE1—atherosclerosis	2.79e-05	0.000156	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—atherosclerosis	2.79e-05	0.000156	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NFKB1—atherosclerosis	2.79e-05	0.000156	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEP—atherosclerosis	2.79e-05	0.000156	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CAV1—atherosclerosis	2.77e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOA1—atherosclerosis	2.76e-05	0.000154	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK8—atherosclerosis	2.74e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—atherosclerosis	2.74e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—atherosclerosis	2.73e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SERPINE1—atherosclerosis	2.68e-05	0.00015	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOS3—atherosclerosis	2.67e-05	0.000149	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ESR1—atherosclerosis	2.67e-05	0.000149	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—F2—atherosclerosis	2.63e-05	0.000147	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK3—atherosclerosis	2.62e-05	0.000146	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—INS—atherosclerosis	2.58e-05	0.000144	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOS3—atherosclerosis	2.56e-05	0.000143	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL2—atherosclerosis	2.54e-05	0.000142	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—atherosclerosis	2.53e-05	0.000142	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—atherosclerosis	2.52e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—atherosclerosis	2.51e-05	0.00014	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1—atherosclerosis	2.5e-05	0.00014	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK3—atherosclerosis	2.41e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK3—atherosclerosis	2.4e-05	0.000134	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—INS—atherosclerosis	2.39e-05	0.000133	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SERPINE1—atherosclerosis	2.37e-05	0.000133	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—atherosclerosis	2.36e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL2—atherosclerosis	2.35e-05	0.000131	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—atherosclerosis	2.33e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1—atherosclerosis	2.31e-05	0.000129	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—atherosclerosis	2.28e-05	0.000128	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—atherosclerosis	2.27e-05	0.000127	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOS3—atherosclerosis	2.27e-05	0.000127	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—atherosclerosis	2.25e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SERPINE1—atherosclerosis	2.19e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—atherosclerosis	2.19e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—atherosclerosis	2.16e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—atherosclerosis	2.14e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NFKB1—atherosclerosis	2.12e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOS3—atherosclerosis	2.09e-05	0.000117	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK8—atherosclerosis	2.08e-05	0.000116	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—atherosclerosis	2.07e-05	0.000116	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—atherosclerosis	2.05e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NFKB1—atherosclerosis	2.03e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—atherosclerosis	2.01e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK8—atherosclerosis	1.99e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—atherosclerosis	1.99e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—atherosclerosis	1.94e-05	0.000109	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—atherosclerosis	1.92e-05	0.000107	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—atherosclerosis	1.91e-05	0.000107	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—atherosclerosis	1.9e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—atherosclerosis	1.86e-05	0.000104	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—atherosclerosis	1.84e-05	0.000103	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—atherosclerosis	1.82e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—atherosclerosis	1.82e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK3—atherosclerosis	1.82e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NFKB1—atherosclerosis	1.8e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—atherosclerosis	1.79e-05	0.0001	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK8—atherosclerosis	1.77e-05	9.89e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—atherosclerosis	1.76e-05	9.86e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—atherosclerosis	1.76e-05	9.86e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—atherosclerosis	1.76e-05	9.85e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—atherosclerosis	1.75e-05	9.8e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK3—atherosclerosis	1.74e-05	9.74e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—atherosclerosis	1.69e-05	9.45e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—atherosclerosis	1.68e-05	9.38e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NFKB1—atherosclerosis	1.66e-05	9.28e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—atherosclerosis	1.63e-05	9.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK8—atherosclerosis	1.63e-05	9.12e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—atherosclerosis	1.63e-05	9.1e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—atherosclerosis	1.62e-05	9.04e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—atherosclerosis	1.62e-05	9.04e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK3—atherosclerosis	1.54e-05	8.63e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—atherosclerosis	1.51e-05	8.42e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—atherosclerosis	1.5e-05	8.38e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—atherosclerosis	1.49e-05	8.34e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK3—atherosclerosis	1.43e-05	7.97e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—atherosclerosis	1.38e-05	7.73e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—atherosclerosis	1.33e-05	7.42e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—atherosclerosis	1.27e-05	7.12e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—atherosclerosis	1.23e-05	6.85e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—atherosclerosis	1.17e-05	6.57e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—atherosclerosis	1.13e-05	6.31e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—atherosclerosis	1.04e-05	5.83e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—atherosclerosis	1.04e-05	5.82e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—atherosclerosis	9.62e-06	5.37e-05	CbGpPWpGaD
